| Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer F Pietrantonio, R Miceli, A Raimondi, YW Kim, WK Kang, RE Langley, ... Journal of Clinical Oncology 37 (35), 3392-3400, 2019 | 367 | 2019 |
| ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer F Pietrantonio, F Di Nicolantonio, AB Schrock, J Lee, S Tejpar, ... Journal of the National Cancer Institute 109 (12), djx089, 2017 | 232 | 2017 |
| Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated … G Fucà, G Galli, M Poggi, GL Russo, C Proto, M Imbimbo, R Ferrara, ... ESMO open 4 (1), e000457, 2019 | 174 | 2019 |
| The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first … G Fucà, V Guarini, C Antoniotti, F Morano, R Moretto, S Corallo, ... British journal of cancer 123 (3), 403-409, 2020 | 141 | 2020 |
| Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in patients with cancer C Vernieri, G Fucà, F Ligorio, V Huber, A Vingiani, F Iannelli, A Raimondi, ... Cancer Discovery 12 (1), 90-107, 2022 | 137 | 2022 |
| Enhancing chimeric antigen receptor T-cell efficacy in solid tumors G Fucà, L Reppel, E Landoni, B Savoldo, G Dotti Clinical cancer research 26 (11), 2444-2451, 2020 | 113 | 2020 |
| RET fusions in a small subset of advanced colorectal cancers at risk of being neglected F Pietrantonio, F Di Nicolantonio, AB Schrock, J Lee, F Morano, G Fucà, ... Annals of Oncology 29 (6), 1394-1401, 2018 | 93 | 2018 |
| Biomarkers of primary resistance to trastuzumab in HER2-positive metastatic gastric cancer patients: the AMNESIA case-control study F Pietrantonio, G Fucà, F Morano, A Gloghini, S Corso, G Aprile, ... Clinical Cancer Research 24 (5), 1082-1089, 2018 | 91 | 2018 |
| Role of chemotherapy, VEGFR inhibitors, and mTOR inhibitors in advanced perivascular epithelioid cell tumors (PEComas) R Sanfilippo, RL Jones, JY Blay, A Le Cesne, S Provenzano, G Antoniou, ... Clinical Cancer Research 25 (17), 5295-5300, 2019 | 86 | 2019 |
| Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case–control study C Cremolini, F Morano, R Moretto, R Berenato, E Tamborini, F Perrone, ... Annals of Oncology 28 (12), 3009-3014, 2017 | 86 | 2017 |
| Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: a retrospective MITO group study F Raspagliesi, G Maltese, G Bogani, G Fucà, S Lepori, P De Iaco, ... Gynecologic Oncology 144 (1), 90-95, 2017 | 84 | 2017 |
| Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors K Hirabayashi, H Du, Y Xu, P Shou, X Zhou, G Fucá, E Landoni, C Sun, ... Nature cancer 2 (9), 904-918, 2021 | 74 | 2021 |
| Negative hyperselection of patients with RAS and BRAF wild-type metastatic colorectal cancer who received panitumumab-based maintenance therapy F Morano, S Corallo, S Lonardi, A Raimondi, C Cremolini, L Rimassa, ... Journal of Clinical Oncology 37 (33), 3099, 2019 | 74 | 2019 |
| The pan-immune-inflammation-value predicts the survival of patients with human epidermal growth factor receptor 2 (Her2)—positive advanced breast cancer treated with first … F Ligorio, G Fucà, E Zattarin, R Lobefaro, L Zambelli, R Leporati, C Rea, ... Cancers 13 (8), 1964, 2021 | 73 | 2021 |
| Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer G Galli, T Triulzi, C Proto, D Signorelli, M Imbimbo, M Poggi, G Fucà, ... Lung Cancer 132, 72-78, 2019 | 68 | 2019 |
| The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors F Corti, S Lonardi, R Intini, M Salati, E Fenocchio, C Belli, B Borelli, ... European journal of cancer 150, 155-167, 2021 | 62 | 2021 |
| KRAS G12C metastatic colorectal cancer: specific features of a new emerging target population M Schirripa, F Nappo, C Cremolini, L Salvatore, D Rossini, M Bensi, ... Clinical Colorectal Cancer 19 (3), 219-225, 2020 | 58 | 2020 |
| Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers G Fucà, R Cohen, S Lonardi, K Shitara, ME Elez, M Fakih, J Chao, ... Journal for immunotherapy of cancer 10 (2), 2022 | 57 | 2022 |
| Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: a systematic review and meta-analysis G Bogani, G Fucà, G Maltese, A Ditto, F Martinelli, M Signorelli, V Chiappa, ... Gynecologic oncology 143 (2), 443-447, 2016 | 55 | 2016 |
| Prognostic impact of ATM mutations in patients with metastatic colorectal cancer G Randon, G Fucà, D Rossini, A Raimondi, F Pagani, F Perrone, ... Scientific reports 9 (1), 2858, 2019 | 49 | 2019 |
Filippo PietrantonioVerified email at istitutotumori.mi.it
